These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Peripherally administered serotonin induces hyperglucagonemia in mice. Yamada J, Sugimoto Y, Kimura I, Watanabe Y, Takeuchi N, Horisaka K. Life Sci; 1993 Aug; 52(23):1845-9. PubMed ID: 8502121 [Abstract] [Full Text] [Related]
10. Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats. Koch JE, Bodnar RJ. Brain Res; 1994 Sep 19; 657(1-2):191-201. PubMed ID: 7820618 [Abstract] [Full Text] [Related]
11. Effects of peripheral 5-HT2 and 5-HT3 receptor agonists on food intake in food-deprived and 2-deoxy-D-glucose-treated rats. Sugimoto Y, Yamada J, Yoshikawa T, Noma T, Horisaka K. Eur J Pharmacol; 1996 Nov 28; 316(1):15-21. PubMed ID: 8982644 [Abstract] [Full Text] [Related]
12. Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex. Pehek EA. Synapse; 1996 Sep 28; 24(1):12-8. PubMed ID: 9046072 [Abstract] [Full Text] [Related]
17. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors. Hewson G, Leighton GE, Hill RG, Hughes J. Br J Pharmacol; 1988 Oct 28; 95(2):598-604. PubMed ID: 2906561 [Abstract] [Full Text] [Related]
18. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat. Danzebrink RM, Gebhart GF. Brain Res; 1991 Jan 04; 538(1):64-75. PubMed ID: 2018933 [Abstract] [Full Text] [Related]